Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Dvorak

Showing results (81-90 of 222) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Pediatric Hematopoietic Cell Transplant Patients Who Survive Critical Illness Frequently Have Significant but Recoverable Decline in Functional StatusMatt S Zinter, Richard Holubkov, Martina A Steurer, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2012
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trialWolf E Mehling, E Anne Lown, Christopher C Dvorak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2022
A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer SurvivorsLeena Chehab, David R Doody, Adam J Esbenshade, et al.
Transplantation and Cellular Therapy|December 1, 2021
Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in ChildrenFederica Forlanini, Matt S Zinter, Christopher C Dvorak, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 5, 2012
Massage for children undergoing hematopoietic cell transplantation: a qualitative reportSara L Ackerman, E Anne Lown, Christopher C Dvorak, et al.
Pediatric Blood & Cancer|March 7, 2022
A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patientsChristine S Higham, Kristin A Shimano, Alexis Melton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell TransplantsCristina F Contreras, Janel R Long-Boyle, Kristin A Shimano, et al.
Blood Advances|April 20, 2021
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxisChristine S Higham, Griffin Collins, Kristin A Shimano, et al.
Journal of Patient Safety|September 27, 2021
Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group ReportTamara P Miller, Melissa Z Marx, Christopher Henchen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Evaluating the use of hierarchical composite endpoints in pediatric cancer supportive care clinical trials: Illustrative examples from two multi-center phase-III randomized clinical trialsWillem H Collier, Mark Zobeck, Adam J Esbenshade, et al.
Pageof 23

Showing results (81-90 of 222) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2017
Pediatric Hematopoietic Cell Transplant Patients Who Survive Critical Illness Frequently Have Significant but Recoverable Decline in Functional StatusMatt S Zinter, Richard Holubkov, Martina A Steurer, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2012
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trialWolf E Mehling, E Anne Lown, Christopher C Dvorak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2022
A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer SurvivorsLeena Chehab, David R Doody, Adam J Esbenshade, et al.
Transplantation and Cellular Therapy|December 1, 2021
Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in ChildrenFederica Forlanini, Matt S Zinter, Christopher C Dvorak, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 5, 2012
Massage for children undergoing hematopoietic cell transplantation: a qualitative reportSara L Ackerman, E Anne Lown, Christopher C Dvorak, et al.
Pediatric Blood & Cancer|March 7, 2022
A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patientsChristine S Higham, Kristin A Shimano, Alexis Melton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell TransplantsCristina F Contreras, Janel R Long-Boyle, Kristin A Shimano, et al.
Blood Advances|April 20, 2021
Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxisChristine S Higham, Griffin Collins, Kristin A Shimano, et al.
Journal of Patient Safety|September 27, 2021
Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group ReportTamara P Miller, Melissa Z Marx, Christopher Henchen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Evaluating the use of hierarchical composite endpoints in pediatric cancer supportive care clinical trials: Illustrative examples from two multi-center phase-III randomized clinical trialsWillem H Collier, Mark Zobeck, Adam J Esbenshade, et al.
Pageof 23